Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid

Giulia Somenzi, Giusy Sala, Stefano Rossetti, Mingqiang Ren, Riccardo Ghidoni, Nicoletta Sacchi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background. Retinoic acid (RA), the bioactive derivative of Vitamin A, by epigenetically controlling transcription through the RA-receptors (RARs), exerts a potent antiproliferative effect on human cells. However, a number of studies show that RA can also promote cell survival and growth. In the course of one of our studies we observed that disruption of RA-receptor alpha, RARα, abrogates the RA-mediated growth-inhibitory effects and unmasks the growth-promoting face of RA (Ren et al., Mol. Cell. Biol., 2005, 25:10591). The objective of this study was to investigate whether RA can differentially govern cell growth, in the presence and absence of RARα, through differential regulation of the "rheostat" comprising ceramide (CER), the sphingolipid with growth-inhibitory activity, and sphingosine-1-phosphate (S1P), the sphingollpid with prosurvival activity. Methodology/Principal findings. We found that functional inhibition of endogenous RARα in breast cancer cells by using either RARα specific antagonists or a dominant negative RARα mutant hampers on one hand the RA-induced upregulation of neutral sphingomyelinase (nSMase)-mediated CER synthesis, and on the other hand the RA-induced downregulation of sphingosine kinase 1, SK1, pivotal for S1P synthesis. In association with RA inability to regulate the sphingolipid rheostat, cells not only survive, but also grow more in response to RA both in vitro and in vivo. By combining genetic, pharmacological and biochemical approaches, we mechanistically demonstrated that RA-induced growth is, at least in part, due to non-RAR-mediated activation of the SK1-S1P signaling. Conclusions/Significance. In the presence of functional' RARα, RA inhibits cell growth by concertedly, and inversely, modulating the CER and S1P synthetic pathways. In the absence of a functional RARα, RA-in a non-RAR-mediated fashion-promotes cell growth by activating the prosurvival S1P signaling. These two distinct, yet integrated processes apparently concur to the growth-promoter effects of RA.

Original languageEnglish (US)
Article numbere836
JournalPloS one
Volume2
Issue number9
DOIs
StatePublished - Sep 5 2007

Fingerprint

Retinoic Acid Receptors
retinoic acid
Tretinoin
promoter regions
receptors
sphingosine
Growth
Ceramides
Cell growth
Sphingolipids
ceramides
phosphates
cell growth
Cells
sphingolipids
Retinoic Acid Receptor alpha
Sphingomyelin Phosphodiesterase
Transcription
Vitamin A
Molecular Biology

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Somenzi, G., Sala, G., Rossetti, S., Ren, M., Ghidoni, R., & Sacchi, N. (2007). Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid. PloS one, 2(9), [e836]. https://doi.org/10.1371/journal.pone.0000836

Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid. / Somenzi, Giulia; Sala, Giusy; Rossetti, Stefano; Ren, Mingqiang; Ghidoni, Riccardo; Sacchi, Nicoletta.

In: PloS one, Vol. 2, No. 9, e836, 05.09.2007.

Research output: Contribution to journalArticle

Somenzi, G, Sala, G, Rossetti, S, Ren, M, Ghidoni, R & Sacchi, N 2007, 'Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid', PloS one, vol. 2, no. 9, e836. https://doi.org/10.1371/journal.pone.0000836
Somenzi, Giulia ; Sala, Giusy ; Rossetti, Stefano ; Ren, Mingqiang ; Ghidoni, Riccardo ; Sacchi, Nicoletta. / Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid. In: PloS one. 2007 ; Vol. 2, No. 9.
@article{53bc4b05458e493ba055be164c141306,
title = "Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid",
abstract = "Background. Retinoic acid (RA), the bioactive derivative of Vitamin A, by epigenetically controlling transcription through the RA-receptors (RARs), exerts a potent antiproliferative effect on human cells. However, a number of studies show that RA can also promote cell survival and growth. In the course of one of our studies we observed that disruption of RA-receptor alpha, RARα, abrogates the RA-mediated growth-inhibitory effects and unmasks the growth-promoting face of RA (Ren et al., Mol. Cell. Biol., 2005, 25:10591). The objective of this study was to investigate whether RA can differentially govern cell growth, in the presence and absence of RARα, through differential regulation of the {"}rheostat{"} comprising ceramide (CER), the sphingolipid with growth-inhibitory activity, and sphingosine-1-phosphate (S1P), the sphingollpid with prosurvival activity. Methodology/Principal findings. We found that functional inhibition of endogenous RARα in breast cancer cells by using either RARα specific antagonists or a dominant negative RARα mutant hampers on one hand the RA-induced upregulation of neutral sphingomyelinase (nSMase)-mediated CER synthesis, and on the other hand the RA-induced downregulation of sphingosine kinase 1, SK1, pivotal for S1P synthesis. In association with RA inability to regulate the sphingolipid rheostat, cells not only survive, but also grow more in response to RA both in vitro and in vivo. By combining genetic, pharmacological and biochemical approaches, we mechanistically demonstrated that RA-induced growth is, at least in part, due to non-RAR-mediated activation of the SK1-S1P signaling. Conclusions/Significance. In the presence of functional' RARα, RA inhibits cell growth by concertedly, and inversely, modulating the CER and S1P synthetic pathways. In the absence of a functional RARα, RA-in a non-RAR-mediated fashion-promotes cell growth by activating the prosurvival S1P signaling. These two distinct, yet integrated processes apparently concur to the growth-promoter effects of RA.",
author = "Giulia Somenzi and Giusy Sala and Stefano Rossetti and Mingqiang Ren and Riccardo Ghidoni and Nicoletta Sacchi",
year = "2007",
month = "9",
day = "5",
doi = "10.1371/journal.pone.0000836",
language = "English (US)",
volume = "2",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid

AU - Somenzi, Giulia

AU - Sala, Giusy

AU - Rossetti, Stefano

AU - Ren, Mingqiang

AU - Ghidoni, Riccardo

AU - Sacchi, Nicoletta

PY - 2007/9/5

Y1 - 2007/9/5

N2 - Background. Retinoic acid (RA), the bioactive derivative of Vitamin A, by epigenetically controlling transcription through the RA-receptors (RARs), exerts a potent antiproliferative effect on human cells. However, a number of studies show that RA can also promote cell survival and growth. In the course of one of our studies we observed that disruption of RA-receptor alpha, RARα, abrogates the RA-mediated growth-inhibitory effects and unmasks the growth-promoting face of RA (Ren et al., Mol. Cell. Biol., 2005, 25:10591). The objective of this study was to investigate whether RA can differentially govern cell growth, in the presence and absence of RARα, through differential regulation of the "rheostat" comprising ceramide (CER), the sphingolipid with growth-inhibitory activity, and sphingosine-1-phosphate (S1P), the sphingollpid with prosurvival activity. Methodology/Principal findings. We found that functional inhibition of endogenous RARα in breast cancer cells by using either RARα specific antagonists or a dominant negative RARα mutant hampers on one hand the RA-induced upregulation of neutral sphingomyelinase (nSMase)-mediated CER synthesis, and on the other hand the RA-induced downregulation of sphingosine kinase 1, SK1, pivotal for S1P synthesis. In association with RA inability to regulate the sphingolipid rheostat, cells not only survive, but also grow more in response to RA both in vitro and in vivo. By combining genetic, pharmacological and biochemical approaches, we mechanistically demonstrated that RA-induced growth is, at least in part, due to non-RAR-mediated activation of the SK1-S1P signaling. Conclusions/Significance. In the presence of functional' RARα, RA inhibits cell growth by concertedly, and inversely, modulating the CER and S1P synthetic pathways. In the absence of a functional RARα, RA-in a non-RAR-mediated fashion-promotes cell growth by activating the prosurvival S1P signaling. These two distinct, yet integrated processes apparently concur to the growth-promoter effects of RA.

AB - Background. Retinoic acid (RA), the bioactive derivative of Vitamin A, by epigenetically controlling transcription through the RA-receptors (RARs), exerts a potent antiproliferative effect on human cells. However, a number of studies show that RA can also promote cell survival and growth. In the course of one of our studies we observed that disruption of RA-receptor alpha, RARα, abrogates the RA-mediated growth-inhibitory effects and unmasks the growth-promoting face of RA (Ren et al., Mol. Cell. Biol., 2005, 25:10591). The objective of this study was to investigate whether RA can differentially govern cell growth, in the presence and absence of RARα, through differential regulation of the "rheostat" comprising ceramide (CER), the sphingolipid with growth-inhibitory activity, and sphingosine-1-phosphate (S1P), the sphingollpid with prosurvival activity. Methodology/Principal findings. We found that functional inhibition of endogenous RARα in breast cancer cells by using either RARα specific antagonists or a dominant negative RARα mutant hampers on one hand the RA-induced upregulation of neutral sphingomyelinase (nSMase)-mediated CER synthesis, and on the other hand the RA-induced downregulation of sphingosine kinase 1, SK1, pivotal for S1P synthesis. In association with RA inability to regulate the sphingolipid rheostat, cells not only survive, but also grow more in response to RA both in vitro and in vivo. By combining genetic, pharmacological and biochemical approaches, we mechanistically demonstrated that RA-induced growth is, at least in part, due to non-RAR-mediated activation of the SK1-S1P signaling. Conclusions/Significance. In the presence of functional' RARα, RA inhibits cell growth by concertedly, and inversely, modulating the CER and S1P synthetic pathways. In the absence of a functional RARα, RA-in a non-RAR-mediated fashion-promotes cell growth by activating the prosurvival S1P signaling. These two distinct, yet integrated processes apparently concur to the growth-promoter effects of RA.

UR - http://www.scopus.com/inward/record.url?scp=41049100486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41049100486&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0000836

DO - 10.1371/journal.pone.0000836

M3 - Article

VL - 2

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e836

ER -